Vuba aha, Ikigo cy’Igihugu gishinzwe Ibikoresho by’Ubuvuzi mu Bushinwa cyemeye ku mugaragaro uburyo bwo kuvura Anlotinib Hydrochloride na Penpulimab bwakozwe na Chia Tai Tianqing mu buryo bwa mbere bwo kuvura kanseri y’umwijima. Ibi bigaragaza ikimenyetso cya cumi cyemewe cya Anlotinib Hydrochloride, bigaragaza uburyo bushya bw’ingenzi mu rwego rwo kuvura kanseri y’umwijima. Ubu buryo bushingiye ku bushakashatsi bwakozwe ku cyiciro cya gatatu cyasohotse mu kinyamakuru cyamamaye ku rwego mpuzamahanga cya *The Lancet Oncology*, gifite amakuru atangaje ku mikorere yacyo azana icyizere gishya ku barwayi ku isi yose.
**Iterambere ry'ubushakashatsi: Rituma umuntu akomeza kubaho kandi rigagabanya ibyago byo kurwara**
Ubushakashatsi bwitwa ALTN-AK105-III-02, ni igerageza ry’icyiciro cya gatatu cy’ubuvuzi rigizwe n’ibice byinshi, ryakozwe ku buryo butaziguye, rifunguye, kandi rigenzurwa mu buryo bunyuranye, ryagenewe gusuzuma imikorere ya Anlotinib Hydrochloride ivanze na Penpulimab ugereranije n’umuti usanzwe wa Sorafenib mu kuvura kanseri y’umwijima iteye imbere. Ubu bushakashatsi bwerekanye abarwayi 649 ba kanseri y’umwijima iteye imbere, muri bo hafi 41% bari bafite indwara z’imitsi migari, naho abagera kuri 49.2% bari bafite poroteyine nyinshi za alpha-feto (≥400 ng/mL). Ibi bimenyetso bikunze kugaragaza imbogamizi zikomeye mu kuvura.
Ibisubizo by'ubushakashatsi birashimishije:
- **Kwiyongera Gukomeye k'ubuzima butagira iterambere:** Igihe cyo hagati cy'ubuzima butagira iterambere mu itsinda ry'abavurwa hakoreshejwe imiti ivanze cyageze ku mezi 6.9, kirenze cyane amezi 2.8 mu itsinda ry'abagenzurwa, hamwe n'igabanuka rya 47% ry'ibyago byo kwiyongera kw'indwara cyangwa urupfu.
- **Iterambere rigaragara mu kubaho muri rusange:** Impuzandengo y'ubuzima muri rusange mu itsinda ry'abavuzi bahuje ubuvuzi yari amezi 16.5, ugereranije n'amezi 13.2 mu itsinda ry'abagenzurwa, bigaragaza ko ibyago byo gupfa byagabanutseho 31%.
Iyi mibare "ifite ingaruka ebyiri nziza" ntabwo igaragaza gusa ibyiza by'ubu buryo bwo kuvura mu gutinza iterambere ry'indwara ahubwo inagaragaza iterambere rikomeye mu byiza rusange byo kubaho, itanga uburyo bwiza bwo kuvura abarwayi ba kanseri y'umwijima.
**Ishami Mpuzamahanga ry'Ibitaro bya Oncology byo mu Karere k'Amajyepfo muri Beijing: Umufatanyabikorwa wawe ku Isi mu Kurwanya Kanseri**
Mu gihe habayeho kanseri, kubona amakuru y’ubuvuzi yemewe n’ubufasha mu buvuzi bw’inzobere ni ingenzi cyane. Ishami Mpuzamahanga ry’Ibitaro Mpuzamahanga bya Oncology bya Beijing mu Karere k’Amajyepfo ryiyemeje gutanga serivisi zirambuye zo gusuzuma kanseri no kuvura abarwayi mpuzamahanga, harimo no gutanga inama ku buryo bugezweho bwo kuvura, gutegura uburyo bwo kuvura bwihariye, no gutanga ubufasha mu itumanaho ry’indimi zitandukanye. Dukorana bya hafi n’ibigo by’ubushakashatsi byo mu gihugu no mu mahanga kugira ngo tumenye neza ko abarwayi bungukira ku ntambwe zigezweho nka Anlotinib Hydrochloride combination therapy.
**Amakuru yo Guhamagara: Turi hano kugira ngo tugukorere**
Niba wowe cyangwa abakunzi bawe mushaka uburyo bwo kuvura kanseri y'umwijima cyangwa izindi kanseri, nyamuneka twandikire vuba ukoresheje uburyo bukurikira. Itsinda ryacu ry'inzobere rizatanga uburyo burambuye bwo kuvura, amabwiriza y'ubuvuzi, n'ubufasha ku barwayi mpuzamahanga:
- **Terefone:** 400-880-3716
Hamagara iyi nomero kugira ngo uvugane n'abahuzabikorwa bacu mpuzamahanga b'abarwayi kugira ngo ubone inama zihuse kandi uhabwe ubufasha bwo kubonana na muganga.
- **WeChat:** 17801183037
Ongeraho konti yacu yemewe ya WeChat kugira ngo ubone amakuru y’ubuvuzi mu buryo bw’igihe nyacyo, ibibazo byo kuri interineti, cyangwa ibiganiro kuri videwo.
- **Imeri:**
① 100085_010@163.com
② myimmnet@163.com
Ohereza inyandiko z'ubuvuzi cyangwa ibibazo kuri imeri yacu, maze itsinda ryacu ry'impuguke rizaguha inama zihariye zo kuvura.
**Kuki twahitamo?**
- **Kubona Uburyo Bugezweho bwo Kuvura:** Dukomeza gukurikirana uburyo bwo kuvura kanseri ku isi kugira ngo abarwayi babone amahirwe yo kubona ibisubizo bishya nka Anlotinib Hydrochloride combination therapy.
- **Serivisi Zindimi Nyinshi:** Dutanga ubufasha mu ndimi nyinshi, harimo n'Icyongereza, kugira ngo dukureho inzitizi mu itumanaho kandi duhe abarwayi mpuzamahanga uburambe bwiza.
- **Ubufasha bwuzuye:** Kuva ku gusaba viza no gucumbika kugeza ku gukurikirana ubuvuzi, dutanga serivisi zo kwita ku buzima bw'umuntu umwe.
Kuvura kanseri ni ukwirukanwa n'igihe. Kwemezwa kwa Anlotinib Hydrochloride combination therapy byazanye icyizere gishya ku barwayi ba kanseri y'umwijima ikomeye. Aho waba uri hose, Ishami Mpuzamahanga ry'Ibitaro bya Oncology bya Beijing Region South Region ryiteguye kuba umufatanyabikorwa wawe uhamye mu rugendo rwawe rwo kurwanya kanseri. Twandikire uyu munsi kugira ngo utangire urugendo rwawe rwo kuvura kanseri!
**Wibuke amakuru yacu yo guhamagara:**
Terefone: 400-880-3716
WeChat: 17801183037
Email: 100085_010@163.com or myimmnet@163.com
Twiteguye kuguha ubufasha bw'ubuvuzi bw'inzobere kandi burangwa n'impuhwe!
Igihe cyo kohereza: Mutarama-27-2026